The role of microglial cell subsets in Alzheimer's disease

Current Alzheimer Research

Volumn 8, Issue 2, 2011, Pages 151-155

  Naert, G ^a   Rivest, S ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Alzheimer's disease; CCR2; Chemokines; Cytokines; Inflammation; Innate immunity; Microglia

Indexed keywords

AMYLOID BETA PROTEIN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; CYTOKINE; TAU PROTEIN; TOLL LIKE RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1;

ALZHEIMER DISEASE; ARTICLE; BONE MARROW CELL; BONE MARROW DERIVED MICROGLIA; CELL ACTIVATION; CELL DIVISION; CELL INFILTRATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CYTOLOGY; DEMENTIA; DISEASE COURSE; GENE THERAPY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOHISTOLOGY; IN UTERO STEM CELL TRANSPLANTATION; IN VITRO STUDY; MACROPHAGE; MICROGLIA; MILD COGNITIVE IMPAIRMENT; MONOCYTE; NEUROPROTECTION; NONHUMAN; OLIGOMERIZATION; PHAGOCYTOSIS; PHOSPHORYLATION; PRIORITY JOURNAL;

EID: 79954518984     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720511795256035     Document Type: Article

References (47)

1. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science (New York, NY. 2002 Oct 25;298(5594):789-91.
2. Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev 8(2): 101-12 (2007).
3. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440(7082): 352-7 (2006).
4. Perry VH, Gordon S. Macrophages and microglia in the nervous system. Trends Neurosci 11(6): 273-7 (1988).
5. Soulet D, Rivest S. Bone-marrow-derived microglia: myth or reality? Curr Opin Pharmacol 8(4): 508-18 (2008).
6. Soulet D, Rivest S. Microglia. Curr Biol 18(12): R506-8 (2008).
7. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8(12): 958-69 (2008).
8. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 13: 453-61 (2008).
9. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 204(12): 3037-47 (2007).
10. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27: 451-83 (2009).
11. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 27: 669-92 (2009).
12. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19(1): 71-82 (2003).
13. Varol C, Yona S, Jung S. Origins and tissue-context-dependent fates of blood monocytes. Immunol Cell Biol 87(1): 30-8 (2009).
14. Kang J, Rivest S. MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis. J Cell Biol 179(6): 1219-30 (2007).
15. Simard AR, Soulet D, Gowing G, Julien JP, Rivest S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49(4): 489-502 (2006).
16. Dickson DW, Farlo J, Davies P, Crystal H, Fuld P, Yen SH. Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. Am J Surg Pathol 132(1): 86-101 (1988).
17. Haga S, Akai K, Ishii T. Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody. Acta neuropathologica 77(6): 569-75 (1989).
18. Malm TM, Koistinaho M, Parepalo M, Vatanen T, Ooka A, Karlsson S, et al. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol Dis 18(1):134-42 (2005).
19. Stalder AK, Ermini F, Bondolfi L, Krenger W, Burbach GJ, Deller T, et al. Invasion of hematopoietic cells into the brain of amyloid precursor protein transgenic mice. J Neurosci 25(48): 11125-32 (2005).
20. Izikson L, Klein RS, Charo IF, Weiner HL, Luster AD. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med 192(7): 1075-80 (2000).
21. Babcock AA, Kuziel WA, Rivest S, Owens T. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci 23(21): 7922-30 (2003).
22. D'Mello C, Le T, Swain MG. Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. J Neurosci 29(7): 2089-102 (2009).
23. Getts DR, Terry RL, Getts MT, Muller M, Rana S, Shrestha B, et al. Ly6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J Exp Med 205(10): 2319-37 (2008).
24. Ishizuka K, Kimura T, Igata-yi R, Katsuragi S, Takamatsu J, Miyakawa T. Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease. Psychiatry Clin Neurosci 51(3): 135-8 (1997).
25. Grammas P, Ovase R. Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol Aging 22(6):837-42 (2001).
26. El Khoury J, Toft M, Hickman SE, Means TK, Terada K, Geula C, et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nature medicine 13(4): 432-8 (2007).
27. Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 155(3): 853-62 (1999).
28. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, et al. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46(6): 860-6 (1999).
29. Selkoe DJ. Biochemistry and Molecular Biology of Amyloid beta-Protein and the Mechanism of Alzheimer's Disease. Handbook of clinical neurology / edited by PJ Vinken and GW. 2008;89:245-60.
30. Lesne S, Kotilinek L, Ashe KH. Plaque-bearing mice with reduced levels of oligomeric amyloid-beta assemblies have intact memory function. Neuroscience 151(3): 745-9 (2008).
31. Cheng IH, Scearce-Levie K, Legleiter J, Palop JJ, Gerstein H, Bien-Ly N, et al. Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J Biol Chem 282(33): 23818-28 (2007).
32. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, et al. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nature neuroscience 8(1):79-84 (2005).
33. Bolmont T, Haiss F, Eicke D, Radde R, Mathis CA, Klunk WE, et al. Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance. J Neurosci. 2008 Apr 16;28(16):4283-92.
34. Mandrekar S, Jiang Q, Lee CY, Koenigsknecht-Talboo J, Holtzman DM, Landreth GE. Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis. J Neurosci 29(13): 4252-62 (2009).
35. Kitazawa M, Yamasaki TR, LaFerla FM. Microglia as a potential bridge between the amyloid beta-peptide and tau. Annals of the New York Academy of Sciences 1035: 85-103 (2004).
36. Li Y, Liu L, Barger SW, Griffin WS. Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J Neurosci 23(5):1605-11 (2003).
37. Richard KL, Filali M, Prefontaine P, Rivest S. Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease. J Neurosci 28(22): 5784-93 (2008).
38. Fuhrmann M, Bittner T, Jung CK, Burgold S, Page RM, Mitteregger G, et al. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease. Nature neuroscience 13(4): 411-3 (2010).
39. Town T, Laouar Y, Pittenger C, Mori T, Szekely CA, Tan J, et al. Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nature medicine 14(6): 681-7 (2008).
40. Mousseau DD, Chapelsky S, De Crescenzo G, Kirkitadze MD, Magoon J, Inoue S, et al. A direct interaction between transforming growth factor (TGF)-betas and amyloid-beta protein affects fibrillogenesis in a TGF-beta receptor-independent manner. The Journal of biological chemistry 278(40): 38715-22 (2003).
41. Wyss-Coray T, Lin C, Sanan DA, Mucke L, Masliah E. Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. Am J Pathol 156(1): 139-50 (2000).
42. Wyss-Coray T, Lin C, Yan F, Yu GQ, Rohde M, McConlogue L, et al. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat Med 7(5): 612-8 (2001).
43. Wyss-Coray T, Masliah E, Mallory M, McConlogue L, Johnson-Wood K, Lin C, et al. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease. Nature 389(6651): 603-6 (1997).
44. Brionne TC, Tesseur I, Masliah E, Wyss-Coray T. Loss of TGFbeta 1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron 40(6): 1133-45 (2003).
45. Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nature medicine 13(11): 1359-62 (2007).
46. Boissonneault V, Filali M, Lessard M, Relton J, Wong G, Rivest S. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease. Brain 132(Pt 4): 1078-92 (2009).
47. Majumdar A, Cruz D, Asamoah N, Buxbaum A, Sohar I, Lobel P, et al. Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils. Mol Biol Cell 18(4): 1490-6 (2007).